Copyright Reports & Markets. All rights reserved.

Global Novel Oral AntiCoagulants (NOAC) Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Novel Oral AntiCoagulants (NOAC) Market Overview

      • 1.1 Product Overview and Scope of Novel Oral AntiCoagulants (NOAC)
      • 1.2 Novel Oral AntiCoagulants (NOAC) Segment by Type
        • 1.2.1 Global Novel Oral AntiCoagulants (NOAC) Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Direct Thrombin Inhibitors
        • 1.2.3 Direct Factor Xa Inhibitors
      • 1.3 Novel Oral AntiCoagulants (NOAC) Segment by Application
        • 1.3.1 Novel Oral AntiCoagulants (NOAC) Consumption Comparison by Application (2014-2025)
        • 1.3.2 Deep Vein Thrombosis (DVT)
        • 1.3.3 Pulmonary Embolism
        • 1.3.4 Acute Coronary Syndrome
        • 1.3.5 Hemodialysis
        • 1.3.6 Others
      • 1.3 Global Novel Oral AntiCoagulants (NOAC) Market by Region
        • 1.3.1 Global Novel Oral AntiCoagulants (NOAC) Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Novel Oral AntiCoagulants (NOAC) Market Size
        • 1.4.1 Global Novel Oral AntiCoagulants (NOAC) Revenue (2014-2025)
        • 1.4.2 Global Novel Oral AntiCoagulants (NOAC) Production (2014-2025)

      2 Global Novel Oral AntiCoagulants (NOAC) Market Competition by Manufacturers

      • 2.1 Global Novel Oral AntiCoagulants (NOAC) Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Novel Oral AntiCoagulants (NOAC) Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Novel Oral AntiCoagulants (NOAC) Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Novel Oral AntiCoagulants (NOAC) Production Sites, Area Served, Product Types
      • 2.5 Novel Oral AntiCoagulants (NOAC) Market Competitive Situation and Trends
        • 2.5.1 Novel Oral AntiCoagulants (NOAC) Market Concentration Rate
        • 2.5.2 Novel Oral AntiCoagulants (NOAC) Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Novel Oral AntiCoagulants (NOAC) Production Market Share by Regions

      • 3.1 Global Novel Oral AntiCoagulants (NOAC) Production Market Share by Regions
      • 3.2 Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Novel Oral AntiCoagulants (NOAC) Production
        • 3.4.1 North America Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
        • 3.4.2 North America Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Novel Oral AntiCoagulants (NOAC) Production
        • 3.5.1 Europe Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
        • 3.5.2 Europe Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Novel Oral AntiCoagulants (NOAC) Production (2014-2019)
        • 3.6.1 China Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
        • 3.6.2 China Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Novel Oral AntiCoagulants (NOAC) Production (2014-2019)
        • 3.7.1 Japan Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
        • 3.7.2 Japan Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Novel Oral AntiCoagulants (NOAC) Consumption by Regions

      • 4.1 Global Novel Oral AntiCoagulants (NOAC) Consumption by Regions
      • 4.2 North America Novel Oral AntiCoagulants (NOAC) Consumption (2014-2019)
      • 4.3 Europe Novel Oral AntiCoagulants (NOAC) Consumption (2014-2019)
      • 4.4 China Novel Oral AntiCoagulants (NOAC) Consumption (2014-2019)
      • 4.5 Japan Novel Oral AntiCoagulants (NOAC) Consumption (2014-2019)

      5 Global Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price Trend by Type

      • 5.1 Global Novel Oral AntiCoagulants (NOAC) Production Market Share by Type (2014-2019)
      • 5.2 Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Type (2014-2019)
      • 5.3 Global Novel Oral AntiCoagulants (NOAC) Price by Type (2014-2019)
      • 5.4 Global Novel Oral AntiCoagulants (NOAC) Production Growth by Type (2014-2019)

      6 Global Novel Oral AntiCoagulants (NOAC) Market Analysis by Applications

      • 6.1 Global Novel Oral AntiCoagulants (NOAC) Consumption Market Share by Application (2014-2019)
      • 6.2 Global Novel Oral AntiCoagulants (NOAC) Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Novel Oral AntiCoagulants (NOAC) Business

      • 7.1 Johnson & Johnson
        • 7.1.1 Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
        • 7.1.2 Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
        • 7.1.3 Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Bristol-Myers Squibb
        • 7.2.1 Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
        • 7.2.2 Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
        • 7.2.3 Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Boehringer Ingelheim
        • 7.3.1 Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
        • 7.3.2 Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
        • 7.3.3 Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Sanofi
        • 7.4.1 Sanofi Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
        • 7.4.2 Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
        • 7.4.3 Sanofi Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Daiichi Sankyo
        • 7.5.1 Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
        • 7.5.2 Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
        • 7.5.3 Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Armatheon
        • 7.6.1 Armatheon Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
        • 7.6.2 Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
        • 7.6.3 Armatheon Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Aspen
        • 7.7.1 Aspen Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
        • 7.7.2 Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
        • 7.7.3 Aspen Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 AstraZeneca
        • 7.8.1 AstraZeneca Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
        • 7.8.2 Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
        • 7.8.3 AstraZeneca Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Bayer
        • 7.9.1 Bayer Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
        • 7.9.2 Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
        • 7.9.3 Bayer Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Cellceutix
        • 7.10.1 Cellceutix Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
        • 7.10.2 Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
        • 7.10.3 Cellceutix Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Cosmo Pharmaceuticals
      • 7.12 CSL Behring
      • 7.13 Eisai
      • 7.14 GSK
      • 7.15 Marathon Pharmaceuticals
      • 7.16 Ockham Biotech
      • 7.17 Perosphere

      8 Novel Oral AntiCoagulants (NOAC) Manufacturing Cost Analysis

      • 8.1 Novel Oral AntiCoagulants (NOAC) Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Novel Oral AntiCoagulants (NOAC)
      • 8.4 Novel Oral AntiCoagulants (NOAC) Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Novel Oral AntiCoagulants (NOAC) Distributors List
      • 9.3 Novel Oral AntiCoagulants (NOAC) Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Novel Oral AntiCoagulants (NOAC) Market Forecast

      • 11.1 Global Novel Oral AntiCoagulants (NOAC) Production, Revenue Forecast
        • 11.1.1 Global Novel Oral AntiCoagulants (NOAC) Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Novel Oral AntiCoagulants (NOAC) Price and Trend Forecast (2019-2025)
      • 11.2 Global Novel Oral AntiCoagulants (NOAC) Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Novel Oral AntiCoagulants (NOAC) Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Novel Oral AntiCoagulants (NOAC) Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Novel Oral AntiCoagulants (NOAC) Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Novel Oral AntiCoagulants (NOAC) Production, Revenue Forecast (2019-2025)
      • 11.3 Global Novel Oral AntiCoagulants (NOAC) Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Novel Oral AntiCoagulants (NOAC) Consumption Forecast (2019-2025)
        • 11.3.2 Europe Novel Oral AntiCoagulants (NOAC) Consumption Forecast (2019-2025)
        • 11.3.3 China Novel Oral AntiCoagulants (NOAC) Consumption Forecast (2019-2025)
        • 11.3.4 Japan Novel Oral AntiCoagulants (NOAC) Consumption Forecast (2019-2025)
      • 11.4 Global Novel Oral AntiCoagulants (NOAC) Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Novel Oral AntiCoagulants (NOAC) Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Novel Oral AntiCoagulants (NOAC) market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Novel Oral AntiCoagulants (NOAC) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Novel Oral AntiCoagulants (NOAC) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Johnson & Johnson
        Bristol-Myers Squibb
        Boehringer Ingelheim
        Sanofi
        Daiichi Sankyo
        Armatheon
        Aspen
        AstraZeneca
        Bayer
        Cellceutix
        Cosmo Pharmaceuticals
        CSL Behring
        Eisai
        GSK
        Marathon Pharmaceuticals
        Ockham Biotech
        Perosphere

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Direct Thrombin Inhibitors
        Direct Factor Xa Inhibitors

        Segment by Application
        Deep Vein Thrombosis (DVT)
        Pulmonary Embolism
        Acute Coronary Syndrome
        Hemodialysis
        Others

        Buy now